ROCHE RECEIVES FDA DE NOVO AUTHORIZATION FOR COBAS® PRO I 601 PLATFORM WITH IONIFY® GABAPENTIN ASSAY, ADVANCING AUTOMATED MASS SPECTROMETRY FOR ROUTINE CLINICAL LABORATORIES

Reuters · 2d ago

Please log in to view news